Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:August 10, 2022Recruiting